4Bai Y,Gao J,Zou DW,et al.Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis:a meta-analysis of randomized controlled trials.Pancreas,2008,37:241-246.
5Sternlieb JM,Aronchick CA,Retig JN,et al.A multicenter,randomized,controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.Am J Gastroenterol,1992,87:1561-1566.
6Zhang Y,Chen QB,Gao ZY,et al.Meta-analysis:octreotide prevents post-ERCP pancreatitis,but only at sufficient doses.Aliment Pharmacol Ther,2009,29:1155-1164.
7Tsujino T,Komatsu Y,Isayama H,et al.Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography:a randomized,controlled trial.Clin Gastroenterol Hepatol,2005,3:376-383.
8Ueki T,Otani K,Kawamoto K,et al.Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis:a prospective,randomized trial.J Gastroenterol,2007,42:161-167.
9Imamura M,Teshima S,Yamauchi H.Effeets of protease inhibitors on the motor activity of canine sphincter of oddi.Nippon Shokakibyo Gakkai Zasshi,1991,88:2729.
2Shuo-Dong Wu, Zhen-Hai Zhang, Jing Kong, Yan-Jun Li, Jun-Zhe Jin, Wei Wang, Dong-Yan Li and Min-Fei Wang Shenyang, China No.2 Department of General Surgery, Second Affilia- ted Hospital, China Medical University, Shenyang 110004, China.Effects of somatostatin analogues on human sphincter of Oddi pressure[J].Hepatobiliary & Pancreatic Diseases International,2005,4(2):302-305. 被引量：8
